Compounded Tirzepatide (GLP-1/GIP)
US$ 23.69
semaglutide compounding pharmacy washington state ABOUT Olympic | Compounding Information
Description
There were 97 exclusions after browsing the title, including 79 review articles or meta-analyses, and another 18 studies were excluded because their subjects were unrelated
The market for GLP-1 RAs is dominated by Novo Nordisk, Eli Lilly, AstraZeneca, Bristol Myers Squibb and GSK
Tirzepatide 10mg/mL Injection tested at 86.8% and 89.1% potency
New: Foundayo (oral GLP-1) at $149/mo self-pay
JAMA 327(6):534545
